Mike Polark
Stock Analyst at Baird
(2.14)
# 2,854
Out of 5,172 analysts
87
Total ratings
40.35%
Success rate
-2.78%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $116.28 | +72.00% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $53.72 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $42.73 | +9.99% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $82.50 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $86.16 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $10.70 | +86.92% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $62.19 | -3.52% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $227.10 | +54.12% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $19.10 | +51.83% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $225.99 | -20.35% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $87.87 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $335.67 | +20.65% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $477.97 | +5.24% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $105.46 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $105.41 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $66.95 | +80.73% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $24.82 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $13.50 | +85.19% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $178.24 | -7.43% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $69.48 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.00 | - | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $3.10 | +577.42% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $220.03 | +13.62% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.15 | +3,639.13% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $116.28
Upside: +72.00%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $53.72
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $42.73
Upside: +9.99%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $82.50
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $86.16
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $10.70
Upside: +86.92%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $62.19
Upside: -3.52%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $227.10
Upside: +54.12%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $19.10
Upside: +51.83%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $225.99
Upside: -20.35%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $87.87
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $335.67
Upside: +20.65%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $477.97
Upside: +5.24%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $105.46
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $105.41
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $66.95
Upside: +80.73%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $24.82
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $13.50
Upside: +85.19%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $178.24
Upside: -7.43%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $69.48
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $13.00
Upside: -
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $3.10
Upside: +577.42%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $220.03
Upside: +13.62%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.15
Upside: +3,639.13%